Marc Riedl on hereditary angioedema
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Marc Riedl on hereditary angioedema
-
Narrated by:
-
By:
Professor Marc Riedl joins us to discuss two trials testing oral deucrictibant for hereditary angioedema attacks: one testing deucrictibant as on-demand therapy to treat attacks and the other testing deucrictibant for prophylaxis of attacks.
Click here to read the full articles:
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00341-2/fulltext
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00004-9/fulltext
Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
No reviews yet